Nautilus Biotechnology, Inc. (NAUT)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 93
-0.05
-4.7203%
$
123.74M Market Cap
- P/E Ratio
- Div Yield
564,441 Volume
-0.74 Eps
$ 0.97
Previous Close 
Want to track NAUT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nautilus Biotechnology, Inc. (NAUT) Statistics
Valuation metrics
Market Cap 123.74M
Enterprise value 127.36M
Trailing P/E (ttm) -1.97
Forward P/E -
PEG ratio -0.13
Price/Sales (ttm) 593.21
Price/Book (mrq) 0.86
Enterprise Value/Revenue 670.32
Enterprise Value/EBITDA -2.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 484.07K
Average volume (90 days) 871.46K
Price summary
52-Week low 0.62
52-Week high 4.31
Beta -
50-Day moving average 1.37
200-Day moving average 2.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -297.48%
Operating margin -330.44%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 10.14%
Book value per share (mrq) 1.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
